Although the findings are inconsistent, it is apparent that perlecan controls cancer progression by regulating interactions between cells and signaling molecules during the various stages, including ECM dysregulation, angiogenesis and invasion, which will be discussed in the following sections. Here, HSPG2 is linked to cancer.